SYK Stock Analysis: Stryker Corp
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degen
- Latest close
- $275.39
- 20-day change
- -13.24%
- Trend state
- BEARISH
- Classification
- Healthcare · Medical - Devices
Market context
Stryker Corp moved -13.24% over the latest 20-session window. BullRecon currently classifies the broader setup as BEARISH.
Latest report
The latest cached company filing period (FY2025 · $25.1B revenue · $3.2B net income) is used alongside annual and quarterly history. Values remain tied to their reported period.
Six-dimension read
Quality is currently the strongest dimension at 5.6/6, while Value is the lowest at 4.0/6. Scores are comparative research signals, not forecasts.